Market Outlook

By 2035, the U.S. Disposable Point-of-Care Testing Devices Market is expected to reach approximately USD 28.95 billion, expanding at a CAGR of 9.65% during the forecast period 2026–2035. The market is estimated at USD 11.52 billion in 2025, following historical expansion from approximately USD 8.26 billion in 2021 to USD 10.41 billion in 2024. Values in this report are expressed in USD billions.

The market encompasses single-use testing components designed to produce diagnostic information at or near the patient rather than in a conventional centralized laboratory. The addressable market includes disposable glucose strips, lateral-flow test devices, rapid diagnostic cards, cartridges and cassettes, single-use molecular test units, coagulation strips, urinalysis strips, pregnancy and fertility tests, infectious-disease kits, cardiac-marker cartridges, drugs-of-abuse tests, specimen-integrated test devices, and other consumables used with portable or benchtop point-of-care systems. Reusable readers, analyzers, meters, and central-laboratory instrumentation are excluded except where their installed base directly drives demand for proprietary disposable consumables.

The economic attractiveness of this market comes from recurring utilization. Unlike reusable diagnostic platforms that depend heavily on capital-equipment replacement cycles, disposable point-of-care products generate revenue every time a patient is tested. A hospital, physician office, emergency department, urgent-care center, pharmacy, or household may retain the same reader for several years while purchasing hundreds or thousands of proprietary strips, cassettes, or cartridges. This creates an installed-base business model in which instrument placements, connectivity, menu expansion, and contracting decisions directly affect long-term consumable revenue.

Demand is supported by a large U.S. testing population. Diabetes affects tens of millions of adults, emergency departments manage more than 150 million patient visits in a typical recent year, U.S. hospitals collectively record more than 35 million admissions, and millions of reportable sexually transmitted infections continue to occur annually. Respiratory infections, pregnancy testing, anticoagulation management, cardiac assessment, renal screening, drug testing, and routine metabolic testing add further recurring volume.

The market is also moving beyond traditional single-analyte strips toward higher-value disposable formats. Multiplex respiratory antigen tests, instrument-read immunoassay cartridges, CLIA-waived molecular cartridges, integrated PCR devices, digitally interpreted test cards, and combined collection-and-detection systems are increasing the revenue generated per diagnostic episode. As a result, market growth through 2035 will depend not only on the number of tests performed but also on a gradual mix shift toward more clinically actionable disposable devices carrying higher average selling prices.

 

Introduction

According to the U.S. Disposable Point-of-Care Testing Devices Market Report, disposable POC diagnostics have evolved from convenience products into an important part of the U.S. diagnostic infrastructure. Their commercial relevance comes from the ability to shorten the time between specimen collection, result generation, and clinical action. In settings such as emergency departments, urgent-care clinics, physician offices, pharmacies, ambulances, community health programs, and homes, avoiding transport to a central laboratory can materially change patient throughput and treatment decisions.

The market sits at the intersection of diagnostics, consumables, decentralized healthcare, and consumer testing. Its product economics therefore differ significantly from conventional laboratory testing. Manufacturers must balance analytical performance, shelf stability, manufacturing scale, specimen simplicity, regulatory classification, ease of interpretation, reimbursement, packaging efficiency, and end-user error risk. A disposable product with strong analytical sensitivity but cumbersome sample preparation may struggle in a waived environment, while a slightly more expensive device that simplifies collection or reduces hands-on steps may create stronger value for the buyer.

Healthcare providers increasingly assess these products according to total workflow economics. A hospital may accept a higher cartridge cost if a rapid result accelerates triage, reduces unnecessary isolation, improves antibiotic stewardship, shortens emergency-department disposition time, or prevents delays in surgery. Urgent-care providers prioritize tests that improve same-visit diagnosis and treatment. Retail pharmacies and community clinics require simple waived workflows, small storage footprints, and predictable per-test economics. Home-testing manufacturers must optimize instructions, collection reliability, packaging, digital interpretation, customer support, and retail distribution.

The U.S. market is particularly attractive because it combines high healthcare utilization with a large installed base of decentralized testing locations and a regulatory framework that enables simple, low-risk tests to operate under CLIA-waived conditions. Over the forecast period, the most important competitive transition will be from low-cost single-analyte disposables toward connected, multiplexed, and molecularly enabled disposable systems capable of producing laboratory-like information closer to the patient.

 

Key Market Drivers: What’s Fueling the U.S. Disposable Point-of-Care Testing Devices Market Boom?

The first major driver is the scale of chronic disease management. Diabetes remains the single most important recurring-use application for disposable point-of-care testing because glucose testing generates repeated demand for strips, lancets, ketone tests, and clinic-based monitoring products. Recent national health data indicate total diabetes prevalence among U.S. adults is above 15% when diagnosed and undiagnosed cases are considered. Although continuous glucose monitoring has changed the diabetes technology landscape, disposable glucose testing remains relevant for confirmation, acute-care testing, newly diagnosed patients, institutional use, lower-cost monitoring, backup testing, and populations without consistent access to continuous systems.

A second major driver is the decentralization of infectious-disease testing. The COVID-19 pandemic fundamentally changed consumer and provider expectations regarding where a diagnostic test can be performed. The longer-term opportunity is no longer dependent on COVID-only products. Influenza, RSV, Group A streptococcus, sexually transmitted infections, HIV, and other infectious diseases are creating a broader decentralized testing ecosystem. Multiplex respiratory products are especially important because a single disposable test can differentiate multiple pathogens associated with similar symptoms and therefore provide greater clinical value than a single-target assay.

A third driver is expansion of CLIA-waived testing. Waived testing enables diagnostic procedures that meet applicable simplicity and low-risk criteria to be performed outside complex laboratories. This creates commercial access to physician offices, urgent-care locations, retail health sites, nursing facilities, outpatient centers, and other decentralized settings. For manufacturers, obtaining waived status can substantially expand the addressable customer base because the product no longer depends exclusively on trained laboratory technologists or moderate-complexity laboratories.

The fourth driver is continued consumer acceptance of self-testing. U.S. households are already familiar with pregnancy tests, ovulation tests, glucose strips, COVID-19 antigen tests, and other home diagnostics. Regulatory progress is broadening this model into more complex applications. The strategic implication is important: the home-testing channel is transitioning from a small group of mature consumer diagnostics into a clinically meaningful extension of healthcare delivery. Products that can generate reliable results without an instrument or use smartphone-assisted interpretation are particularly well positioned.

A fifth driver is acute-care workflow economics. The United States records more than 150 million emergency-department visits in a recent year, creating enormous demand for rapid decision-making. Point-of-care blood gas, electrolyte, glucose, lactate, cardiac-marker, coagulation, urinalysis, pregnancy, and infectious-disease tests can eliminate the delay associated with specimen transportation, accessioning, laboratory queues, and electronic result release. In time-sensitive settings, minutes can influence patient disposition, medication choice, isolation strategy, surgery readiness, and escalation of care.

Hospital procurement therefore increasingly evaluates the disposable cost within the economics of the entire patient episode. A USD 15, USD 30, or USD 50 cartridge cannot be assessed only against a central-laboratory reagent cost if it changes length of stay, nursing utilization, emergency-department throughput, or bed availability. Manufacturers able to quantify these downstream effects can defend premium pricing more effectively than suppliers competing primarily on test cost.

A sixth driver is the recurring-revenue nature of proprietary consumables. Analyzer placements often function as gateways to multi-year consumable demand. Once a health system validates a platform, trains staff, integrates results with the electronic medical record, builds quality-control protocols, and standardizes purchasing, switching becomes operationally expensive. This can give manufacturers with large installed bases meaningful customer retention and predictable recurring revenue. Consequently, pricing strategy frequently involves instrument placement, reagent-rental agreements, volume commitments, integrated service contracts, and system-level purchasing agreements.

Another driver is the substantial U.S. burden of sexually transmitted infections. More than two million reportable cases of chlamydia, gonorrhea, and syphilis continue to be recorded in the country annually. Traditional testing workflows can involve delayed results and loss to follow-up. Faster disposable molecular or immunoassay formats can potentially close the gap between screening, diagnosis, counseling, and treatment. The FDA authorization of fully at-home molecular testing for selected sexually transmitted infections demonstrates that complex diagnostic categories can increasingly move closer to patients.

Pregnancy and fertility testing also provides a stable recurring consumer-testing base. The United States records more than 3.6 million births annually, while actual pregnancy-testing volume is substantially larger because tests are performed before confirmed pregnancies, during fertility management, after missed periods, before procedures, and in clinical settings. Disposable urine hCG and ovulation tests therefore remain a resilient retail and professional market despite being technologically mature.

Finally, reimbursement pressure itself is supporting carefully targeted POC adoption. U.S. providers are under pressure to shorten care episodes, increase outpatient capacity, manage labor shortages, and improve patient experience. Point-of-care testing does not reduce cost in every circumstance, but where faster information changes a clinical decision, it can generate measurable operational value. This makes clinical utility and workflow impact increasingly important determinants of procurement.

 

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in disposable point-of-care testing is moving toward higher information density per test. The traditional model of one disposable device producing one qualitative answer is being replaced by multiplex formats that test several clinically related targets simultaneously. Respiratory testing illustrates this transition. Newer disposable assays can differentiate combinations of SARS-CoV-2, influenza A, influenza B, and RSV from one collected specimen, increasing the relevance of testing during respiratory seasons when symptoms overlap.

Single-use molecular diagnostics represent another important innovation cycle. Molecular testing historically required centralized laboratory infrastructure, skilled personnel, separate extraction processes, and longer workflows. Microfluidics, miniaturized thermal cycling, integrated sample preparation, and cartridge engineering are enabling nucleic-acid amplification in compact or fully disposable formats. These products carry higher per-test prices than conventional lateral-flow assays but can offer stronger sensitivity and more clinically definitive results.

Manufacturers are also improving sample-to-answer integration. Reducing pipetting, transfers, timing steps, external reagents, and manual interpretation can make a product more suitable for waived environments. The ideal disposable POC device increasingly combines specimen collection, metering, reagent storage, reaction, detection, and waste containment in one closed format. This reduces training burden and potential contamination while improving reproducibility across non-laboratory users.

Digital interpretation is becoming another differentiator. Disposable strips and test cards may remain physically simple, but smartphone applications or reusable readers can provide automated interpretation, timestamping, patient identification, quality checks, connectivity, and electronic reporting. For health systems, connectivity addresses one of the historical weaknesses of decentralized testing: results that do not reach the electronic medical record. For home users, digital guidance can reduce interpretation errors and help direct appropriate follow-up.

Innovation is also occurring in multiplex sexual-health testing. The emergence of home-based molecular testing for chlamydia, gonorrhea, and trichomoniasis demonstrates that high-value testing can move from laboratory workflows to self-collected specimens and disposable integrated systems. Over the forecast period, similar approaches are likely to expand into additional infectious-disease and reproductive-health categories where privacy, convenience, and loss to follow-up are material barriers.

Blood-based cartridges are advancing through smaller specimen requirements and broader analyte menus. Acute-care customers increasingly favor products that can obtain several measurements from a small capillary or whole-blood sample while minimizing preparation. This is particularly relevant in neonatal, pediatric, emergency, critical-care, and ambulatory settings where specimen conservation or rapid turnaround is important.

Manufacturing innovation will become equally important. Disposable diagnostics require reliable membrane chemistry, antibodies, enzymes, plastics, desiccants, microfluidic structures, sensors, packaging, and sterilized or contamination-controlled components at very high production volumes. During public-health surges, manufacturing capacity can become a competitive advantage. Buyers are consequently paying greater attention to domestic supply resilience, dual sourcing, shelf life, lot-to-lot consistency, and inventory planning.

Environmental pressure is emerging as a longer-term design consideration. Single-use diagnostics inherently generate plastic, foil, paper, swab, reagent, and packaging waste. Hospitals with sustainability targets will increasingly scrutinize device material intensity, packaging volume, hazardous-waste classification, and disposal burden. Manufacturers that reduce material without compromising biosafety or shelf life could create procurement differentiation, particularly in large integrated delivery networks.

 

Segmentation Insights

The U.S. Disposable Point-of-Care Testing Devices Market is segmented on the basis of product format, application, sample type, end user, and technology type.

 

By Product Format

Test Strips and Dipsticks

Test strips and dipsticks represent the largest mature product class and are estimated to account for approximately 32.5% of the 2025 market, equivalent to about USD 3.74 billion. The segment includes blood glucose strips, urine reagent strips, ketone strips, coagulation-related strips, renal screening strips, and other dry-chemistry formats. The key commercial advantage is extremely low instrument complexity and high recurring volume.

Glucose testing is the anchor application, while urinalysis and renal risk screening provide additional institutional demand. Growth is lower than in molecular cartridges, but the enormous installed base, low cost per test, and chronic-disease testing frequency make strips a durable revenue pool.

Disposable Cartridges and Cassettes

Disposable cartridges and cassettes represent an estimated 26.8% share, or approximately USD 3.09 billion in 2025. These consumables are commonly used with blood gas systems, cardiac-marker analyzers, coagulation platforms, immunoassay readers, molecular systems, and multiplex diagnostic instruments.

This segment is strategically attractive because cartridges can command materially higher prices than basic strips while remaining tied to proprietary analyzers. The combination of installed-base lock-in, broader analyte menus, and acute-care clinical utility supports recurring revenue and stronger manufacturer margins.

Lateral-Flow Cards and Rapid Test Kits

Lateral-flow devices account for roughly 23.4% of the market, representing approximately USD 2.70 billion in 2025. Products include rapid respiratory tests, pregnancy tests, HIV tests, strep tests, infectious-disease cards, drug tests, and related visually interpreted or reader-assisted formats.

The segment experienced extraordinary visibility during COVID-19 and is now entering a post-pandemic replacement cycle characterized by multiplex testing rather than COVID-only volume. Competitive success increasingly depends on respiratory combinations, stronger sensitivity, shelf stability, OTC access, and retail distribution.

Collection-Integrated Disposable Devices

Collection-integrated products represent approximately 9.6% of 2025 revenue, or around USD 1.11 billion. These formats combine swabs, collection chambers, capillary sampling devices, reagent reservoirs, test chambers, or other specimen-handling functions into a single-use workflow.

Demand is increasing because specimen handling is a major source of user error in decentralized settings. Products that minimize pipetting and transfer steps are better suited for pharmacies, physician offices, home use, and other low-complexity environments.

Single-Use Microfluidic and Molecular Devices

Single-use microfluidic and molecular devices account for an estimated 7.7%, or approximately USD 0.89 billion in 2025, but represent the fastest-growing product format. Their contribution is expected to rise disproportionately through 2035 as molecular amplification, microfluidic control, and multiplex detection move into disposable systems.

The key commercial tradeoff is price versus diagnostic certainty. These devices cost more per test than conventional lateral flow but may reduce confirmatory testing or accelerate treatment. Applications in respiratory disease, sexual health, and other infectious diseases will drive expansion.

 

By Application

Diabetes and Metabolic Monitoring

Diabetes and metabolic testing is estimated to represent approximately 31.0% of 2025 market revenue, or about USD 3.57 billion. The segment includes glucose strips, ketone tests, HbA1c-related POC consumables, renal screening products, and disposable chemistry devices used in hospitals and ambulatory care.

Competition from continuous glucose monitoring will moderate conventional home blood-glucose-strip growth, but disposable testing remains deeply embedded in hospital protocols, nursing facilities, acute care, backup testing, affordability-sensitive populations, and professional diabetes management.

Infectious Disease Testing

Infectious disease testing represents approximately 27.5%, equivalent to about USD 3.17 billion in 2025, and is expected to be one of the most dynamic application areas. Respiratory infections, strep, HIV, sexually transmitted infections, and other communicable diseases support demand across professional and consumer channels.

The next growth phase is shifting from pandemic-specific testing toward multiplex and disease-specific decentralization. Tests that influence immediate antiviral use, antibiotic prescribing, isolation, or referral decisions will command greater clinical value than screening products with limited treatment implications.

Pregnancy and Fertility Testing

Pregnancy and fertility testing represents an estimated 11.8% share, or approximately USD 1.36 billion. Urine hCG pregnancy tests and ovulation-prediction tests remain highly established disposable consumer diagnostics with broad retail availability.

Innovation is incremental compared with molecular infectious-disease testing, but this segment benefits from strong consumer awareness, repeat purchasing, digital fertility ecosystems, and continued clinical use before medications, imaging procedures, anesthesia, or treatment decisions where pregnancy status may be relevant.

Cardiac, Coagulation and Critical-Care Testing

Cardiac, coagulation, and acute-care applications account for approximately 12.9% of the market, or around USD 1.49 billion in 2025. Disposable cartridges are used for troponin, blood gas, electrolytes, lactate, coagulation measurements, and related urgent clinical assessments.

These products have strong economic justification when immediate results change treatment. Emergency departments, intensive-care units, operating rooms, ambulances, and procedural settings value rapid information, making turnaround time and reliability more important than the lowest reagent price.

Drugs-of-Abuse, Renal, Urinalysis and Other Applications

The remaining application group represents approximately 16.8%, or USD 1.94 billion in 2025. It includes drugs-of-abuse testing, urinalysis, renal screening, fecal occult blood tests, cholesterol tests, selected allergy or inflammatory markers, and other decentralized diagnostics.

This segment is heterogeneous but commercially important because it spans workplace testing, clinical monitoring, preventive care, occupational medicine, community health, and routine physician-office workflows.

 

By Sample Type

Capillary and Whole Blood

Blood-based testing is estimated to account for approximately 47% of 2025 revenue, making it the largest sample category. Glucose, blood gas, electrolytes, coagulation, cardiac markers, lactate, ketones, HbA1c, and other acute-care analytes support high recurring volume.

Growth is being supported by lower sample-volume requirements, improved capillary collection, closed cartridges, and broader menus that can generate multiple results from a single specimen.

Nasal and Nasopharyngeal Samples

Nasal specimens represent approximately 21% of the market, driven predominantly by respiratory infectious-disease testing. Anterior nasal collection has become particularly important because it is easier for consumers and non-laboratory personnel than deep nasopharyngeal collection.

Multiplex flu, COVID-19, and RSV testing is expected to sustain this sample category well beyond the pandemic era.

Urine

Urine accounts for approximately 16% of market revenue and supports pregnancy, fertility, urinalysis, drug testing, ketone testing, renal assessment, and selected infectious-disease applications.

The advantages are noninvasive collection, low consumable cost, and familiarity across professional and home users. Digital readers and semi-automated strip interpretation are improving consistency in professional settings.

Saliva and Oral Fluid

Saliva and oral-fluid testing contributes an estimated 8.5% of revenue. Applications include HIV screening, drugs-of-abuse testing, infectious disease, and emerging molecular diagnostics.

The sample type is commercially attractive because noninvasive collection can improve user acceptance and reduce phlebotomy requirements. Expansion will depend on achieving analytical performance comparable with more established specimen types.

Other Specimens

Other specimen types, representing approximately 7.5%, include vaginal swabs, throat swabs, stool, wound-related samples, and application-specific specimens. Sexual-health testing is particularly relevant as self-collected vaginal specimens gain a more important role in decentralized molecular testing.

 

By End User

Hospitals and Health Systems

Hospitals and health systems account for an estimated 33% of 2025 revenue, making them the largest institutional purchasers. Emergency departments, ICUs, operating rooms, labor and delivery units, inpatient wards, procedural areas, and hospital outpatient departments collectively consume large volumes of disposable cartridges and strips.

Large health systems frequently standardize POC platforms across facilities. Procurement decisions therefore affect substantial multi-year consumable volumes and are increasingly negotiated at enterprise level.

Physician Offices and Urgent-Care Centers

Physician offices and urgent-care centers represent approximately 23% of the market. Their demand centers on respiratory disease, strep testing, pregnancy testing, urinalysis, glucose, HbA1c, and other tests that enable a diagnosis or treatment decision during the same appointment.

Rapid turnaround is central to the business model because sending patients to outside laboratories can delay treatment and reduce patient satisfaction.

Home and Self-Testing

Home testing contributes approximately 21% of market revenue and is expected to gain share through 2035. Diabetes, pregnancy, fertility, respiratory disease, HIV, sexual health, and other applications are expanding the number of diagnostic decisions occurring outside traditional facilities.

The most successful home products will combine simple collection, clear instructions, high analytical reliability, retail accessibility, privacy, and an obvious next action after the result.

Retail Pharmacies and Community Health Settings

Retail pharmacies, public-health programs, community clinics, and similar decentralized locations represent around 13% of market revenue. Their role is growing as pharmacies move beyond dispensing toward vaccination, screening, minor-illness services, and chronic-disease support.

CLIA-waived products are particularly important because these sites require simple workflows with minimal laboratory infrastructure.

Ambulatory, Post-Acute, Employer and Other Settings

Ambulatory surgery centers, nursing facilities, home-health organizations, employers, occupational-health providers, correctional facilities, schools, and emergency medical services collectively represent approximately 10% of the market.

These settings prioritize portability, rapid results, low training requirements, and predictable per-test economics. Demand is fragmented but creates attractive opportunities for manufacturers with strong distributor networks.

 

By Technology Type

Electrochemical and Biosensor-Based Testing

Electrochemical testing accounts for approximately 30% of the 2025 market, primarily because of glucose monitoring and blood-based sensor cartridges. The technology provides rapid quantitative results and can be manufactured at high scale.

Future growth will come from multi-analyte biosensors, improved enzyme stability, reduced sample requirements, and integration with connected readers.

Lateral-Flow Immunoassays

Lateral-flow technology represents approximately 29% of revenue. Its low cost, visual interpretation, portability, and compatibility with OTC and waived workflows make it one of the most commercially successful diagnostic formats.

The next phase is centered on multiplex respiratory testing, improved detection chemistry, digital reading, and more robust quantitative or semi-quantitative interpretation.

Instrument-Read Immunofluorescence and Immunoassays

Instrument-read immunoassays account for approximately 15% of revenue. Disposable test cassettes are paired with compact readers that improve interpretation and may offer greater analytical sensitivity than purely visual lateral flow.

These systems are particularly well suited to urgent-care and physician-office environments where moderate test volumes justify a small reusable instrument.

Molecular Cartridge and Integrated Nucleic-Acid Testing

Molecular technology represents approximately 14% of 2025 revenue but is expected to record the strongest value growth through 2035. Proprietary cartridges and fully integrated single-use molecular devices command premium prices because they deliver higher diagnostic information density.

Respiratory and sexual-health testing will be major growth areas, with additional opportunities in gastrointestinal, healthcare-associated, and other infectious diseases.

Dry Chemistry, Microfluidics and Other Disposable Technologies

Dry chemistry, microfluidics, optical technologies, and other formats collectively represent approximately 12% of the market. These technologies support urinalysis, metabolic measurements, specialty testing, and next-generation miniaturized diagnostics.

The segment will become increasingly important as manufacturers combine microfluidic sample control with optical, electrochemical, or molecular detection in closed disposable systems.

 

Regional Insights: Where the Market is Growing Fastest

The U.S. Disposable Point-of-Care Testing Devices Market is geographically segmented into the South, West, Northeast, and Midwest. Regional performance is influenced by population scale, chronic-disease prevalence, hospital utilization, retail pharmacy penetration, elderly demographics, urgent-care density, public-health testing needs, payer mix, rural access, and the adoption rate of decentralized diagnostics.

The South is the largest regional market in 2025, while the West is expected to record the fastest growth through 2035. The Northeast remains a high-value market characterized by sophisticated health systems and rapid adoption of clinically differentiated diagnostics, while the Midwest provides a large recurring base of hospital, diabetes, rural-health, and physician-office testing.

South

The South represents an estimated USD 4.20 billion in 2025 and is projected to approach approximately USD 10.80 billion by 2035, reflecting an estimated CAGR near 9.9%. For this market analysis, the region includes Texas, Florida, Georgia, North Carolina, Virginia, Tennessee, Maryland, South Carolina, Alabama, Louisiana, Kentucky, Oklahoma, Arkansas, Mississippi, West Virginia, and the District of Columbia market.

Texas and Florida are the two most strategically important markets. Texas combines very large metropolitan healthcare systems with extensive rural and suburban populations. Houston, Dallas-Fort Worth, Austin, and San Antonio contain large hospital networks, urgent-care operators, specialty practices, and retail health infrastructure. This supports demand across glucose testing, infectious-disease testing, blood-based cartridges, pregnancy testing, and occupational health.

Florida has particularly favorable demographics for chronic-disease and acute-care testing because of its large older population. Diabetes monitoring, coagulation, renal testing, respiratory testing, and rapid hospital-based diagnostics therefore represent important demand pools. The state’s tourism and seasonal population movement also create large urgent-care and retail testing volumes.

North Carolina, Georgia, Tennessee, and Virginia are attractive expansion markets because of population growth, health-system consolidation, biotechnology infrastructure, and growing outpatient networks. North Carolina’s research-oriented healthcare ecosystem can support adoption of emerging molecular technologies, while Atlanta, Nashville, Charlotte, Raleigh-Durham, and Northern Virginia create dense metropolitan demand.

Louisiana, Mississippi, Alabama, Kentucky, Arkansas, Oklahoma, and West Virginia provide a different opportunity profile. Higher chronic-disease burdens and more significant rural-access challenges create demand for simple testing that can be deployed outside tertiary medical centers. Diabetes strips, renal screening, infectious-disease tests, and compact cartridge systems can improve access where central laboratories are geographically distant.

The South is also important for sexual-health testing. Recent HIV surveillance continues to show that the region accounts for more than half of newly diagnosed HIV cases nationally. Combined with substantial STI burden, this creates a strong case for community-based, pharmacy-based, home, and public-health testing.

Manufacturers that succeed in the South will need a dual commercial strategy: enterprise contracting for large health systems and broad distribution for smaller physician offices, rural facilities, pharmacies, and consumer channels.

West

The West represented an estimated USD 2.79 billion in 2025 and is forecast to reach approximately USD 7.64 billion by 2035, corresponding to an above-market CAGR of roughly 10.6%. The region includes California, Washington, Oregon, Arizona, Nevada, Utah, Colorado, New Mexico, Idaho, Montana, Wyoming, Alaska, and Hawaii.

California is the dominant state market and one of the country’s most important launch environments for next-generation POC diagnostics. Its large population, academic medical centers, biotechnology industry, digital-health ecosystem, retail pharmacy footprint, and consumer acceptance of home health technologies support premium and digitally integrated disposable tests.

California is especially attractive for molecular self-testing, smartphone-supported diagnostics, respiratory multiplexing, sexual-health testing, and high-throughput hospital cartridge systems. Manufacturers can use leading academic and integrated health systems in the state to generate clinical experience before wider national commercialization.

Arizona and Nevada are high-growth markets because of population expansion, aging demographics, and rapid development of outpatient healthcare infrastructure. Respiratory testing, diabetes management, urgent-care diagnostics, and senior-care applications are likely to generate above-average consumable demand.

Washington, Oregon, Colorado, and Utah have comparatively sophisticated integrated delivery systems and strong adoption of digital-health workflows. Connectivity between POC testing and electronic health records is especially relevant in these markets. Health systems may favor products that provide centralized device management, operator controls, quality monitoring, and automatic result transmission.

New Mexico, Idaho, Montana, Wyoming, Alaska, and Hawaii are smaller markets by absolute revenue but strategically important for decentralized care. Long travel distances and uneven access to centralized laboratories create a strong clinical argument for compact and portable testing. Products that are shelf stable, simple to operate, and usable with limited infrastructure can address rural clinics, tribal-health programs, emergency medical services, critical-access hospitals, and remote communities.

The West is forecast to gain share through 2035 because it combines high consumer adoption of home testing with early clinical adoption of advanced molecular and connected diagnostic technologies.

Northeast

The Northeast accounts for an estimated USD 2.43 billion in 2025 and is projected to reach approximately USD 5.81 billion by 2035, representing an estimated CAGR near 9.1%. The regional grouping includes New York, Pennsylvania, New Jersey, Massachusetts, Connecticut, Rhode Island, New Hampshire, Vermont, Maine, and Delaware.

New York is the largest market in the region because of its population scale, dense hospital network, emergency-care volumes, physician practices, public-health programs, and large retail pharmacy channel. New York City alone represents a concentrated environment for respiratory, sexual-health, pregnancy, drug, and acute-care testing.

Massachusetts is disproportionately important relative to population because of its academic medical centers, diagnostics research base, biotechnology ecosystem, and willingness to evaluate emerging technologies. Novel molecular tests and high-value clinical cartridges can gain early validation in these institutions.

Pennsylvania and New Jersey provide substantial hospital and ambulatory testing volumes and are important commercial territories for national diagnostics manufacturers. Philadelphia, Pittsburgh, northern New Jersey, and the New York metropolitan corridor support large physician-office, emergency, urgent-care, and reference-laboratory networks.

Connecticut and the smaller New England states represent mature healthcare markets where health-system integration, quality control, and standardization are important procurement factors. Rural areas of Maine, Vermont, and New Hampshire also create selective opportunities for decentralized testing when transport to centralized laboratory facilities would delay results.

The Northeast generally has rigorous value-analysis processes. Manufacturers seeking enterprise adoption may need to demonstrate analytical performance, operator usability, connectivity, quality-management capability, supply reliability, and measurable workflow improvement. Premium pricing is possible, but buyers often demand stronger evidence than simply showing faster turnaround.

Midwest

The Midwest represented approximately USD 2.10 billion in 2025 and is projected to reach around USD 4.70 billion by 2035, reflecting an estimated CAGR near 8.4%. The region includes Illinois, Ohio, Michigan, Minnesota, Indiana, Wisconsin, Missouri, Iowa, Kansas, Nebraska, North Dakota, and South Dakota.

Illinois, Ohio, Michigan, and Minnesota represent the largest state opportunities. Chicago supports a large academic and community hospital ecosystem, while Ohio has extensive regional health systems and significant acute-care capacity. Michigan has large recurring demand for diabetes, infectious-disease, and hospital POC products.

Minnesota is strategically important because of its medtech heritage and sophisticated provider environment. The state can serve as an evaluation market for devices that integrate diagnostics, connectivity, and workflow management.

Indiana, Wisconsin, and Missouri provide significant health-system and physician-office volumes. These states are attractive for manufacturers that offer standardized system contracts, reliable distribution, and competitive consumable economics rather than relying solely on premium innovation.

Iowa, Kansas, Nebraska, North Dakota, and South Dakota have smaller populations but present strong use cases for decentralized testing. Rural facilities and critical-access hospitals can benefit substantially from tests that reduce specimen transport and provide immediate clinical information locally.

The Midwest is unlikely to outgrow the West or South, but it offers durable recurring demand. Suppliers with broad menus, dependable customer service, distributor relationships, and cost-effective contracts are likely to perform well.

 

Key Market Players

The U.S. Disposable Point-of-Care Testing Devices competitive landscape is moderately consolidated in high-volume categories but highly fragmented across individual test applications. Global diagnostics manufacturers dominate proprietary cartridge and installed-base businesses, while specialist companies compete effectively in home testing, lateral flow, molecular POC testing, glucose monitoring, sexual health, and niche rapid diagnostics.

Some of the key companies active in or strategically relevant to the U.S. market include Abbott Laboratories; Roche Diagnostics; Danaher Corporation through Cepheid; QuidelOrtho Corporation; Becton, Dickinson and Company; Siemens Healthineers; bioMérieux; Hologic; Thermo Fisher Scientific; QIAGEN; Bio-Rad Laboratories; Nova Biomedical; EKF Diagnostics; OraSure Technologies; Trinity Biotech; Sekisui Diagnostics; ACON Laboratories; iHealth Labs; Access Bio; InBios International; Visby Medical; binx health; PTS Diagnostics; ARKRAY USA; and Werfen.

Abbott has one of the broadest positions because it participates across glucose monitoring, rapid infectious-disease testing, blood-based POC cartridges, and other decentralized diagnostics. Its installed analyzer base provides recurring consumable demand and creates opportunities for system-level hospital contracting.

Roche, Danaher/Cepheid, Siemens Healthineers, BD, QuidelOrtho, and bioMérieux compete across professional POC environments with various combinations of molecular, immunoassay, respiratory, blood-based, and acute-care systems. Their competitive advantage lies not only in assay performance but also in service infrastructure, instrument installed base, menu depth, regulatory capabilities, and large-enterprise contracting.

ACON, iHealth, Access Bio, InBios, and other rapid-test manufacturers are important in the expanding consumer and respiratory-testing market. Retail access, manufacturing scale, price discipline, packaging, and regulatory transition from emergency pathways toward traditional clearances are becoming increasingly important.

Visby Medical is strategically notable because fully integrated single-use molecular testing challenges the conventional distinction between an instrument and a disposable. Such technologies could create a new premium class of consumable diagnostics capable of delivering molecular results without conventional laboratory infrastructure.

Competition through 2035 will increasingly center on menu breadth, test accuracy, time to result, CLIA-waiver status, OTC authorization, specimen simplicity, digital connectivity, supply reliability, cost per actionable result, and the ability to integrate testing into clinical or consumer follow-up pathways.

 

Recent Developments

Recent regulatory developments demonstrate that the U.S. market is moving from pandemic-era emergency testing toward a durable decentralized diagnostics framework.

In October 2024, the FDA granted traditional marketing authorization to an over-the-counter test capable of detecting influenza A, influenza B, and COVID-19 at home. This development was strategically important because it showed that multiplex respiratory self-testing could persist outside temporary emergency-use pathways. It also established a regulatory precedent for companies seeking to commercialize seasonal respiratory combinations as routine consumer diagnostics.

During 2025, the respiratory self-testing market broadened further. Additional COVID-19 and influenza combination tests received traditional clearances, and manufacturers expanded toward multi-analyte products covering RSV alongside influenza and COVID-19. This changes the category from a pandemic product market into a broader seasonal respiratory diagnostics market.

Another major development occurred in March 2025, when the FDA authorized the first fully at-home diagnostic test for chlamydia, gonorrhea, and trichomoniasis that could be purchased without a prescription and performed entirely at home. The disposable molecular system provides results in approximately 30 minutes. Strategically, this is more significant than one product launch: it validates the possibility of moving higher-complexity sexual-health diagnostics directly into the consumer environment.

The FDA’s CLIA-waiver activity during late 2025 and 2026 also illustrates broadening innovation. New waived assays have included respiratory tests, Strep A products, urine albumin-to-creatinine ratio testing, multiplex molecular respiratory panels, and tests designed to help distinguish bacterial from non-bacterial infection. Each waived authorization expands the number of non-laboratory locations capable of using the relevant disposable test.

In 2026, regulatory activity continued around integrated molecular respiratory testing. The commercialization of compact and single-use molecular formats is likely to raise competitive pressure on both conventional lateral-flow products and larger cartridge-based POC analyzers.

The market is therefore entering a period where differentiation will increasingly come from combining laboratory-grade information with consumer-grade simplicity. Companies able to reduce sample preparation while improving multiplexing, digital interpretation, and regulatory access will be positioned to capture the fastest-growing portions of the market.

 

Conclusion

The U.S. Disposable Point-of-Care Testing Devices Market Size & Share is positioned for sustained expansion from an estimated USD 11.52 billion in 2025 to USD 28.95 billion by 2035, representing a 9.65% CAGR during 2026–2035. Historical market value increased from approximately USD 8.26 billion in 2021 to USD 10.41 billion in 2024, despite normalization of pandemic-era testing demand, because decentralized diagnostics continued to expand into chronic disease, respiratory testing, acute care, reproductive health, and other applications.

The market’s core economic strength is recurring utilization. Each glucose strip, test card, assay cassette, molecular cartridge, blood-analysis cartridge, pregnancy test, or respiratory self-test is consumed once and must be replaced. This creates a recurring-revenue profile that can be more predictable than capital-equipment sales and rewards manufacturers that establish proprietary installed bases.

The strongest future growth is expected in molecular disposable devices, multiplex respiratory diagnostics, at-home testing, connected immunoassays, sexual-health testing, renal and chronic-disease screening, and closed sample-to-answer cartridges. Mature products such as glucose strips, pregnancy tests, urinalysis strips, and basic lateral-flow assays will remain large markets, but they will face stronger pricing pressure.

Hospitals will remain the largest institutional customer group, but the market will become progressively more decentralized. Urgent-care operators, physician offices, pharmacies, community programs, homes, ambulatory facilities, and rural healthcare providers will account for a growing proportion of incremental testing.

Regionally, the South is expected to remain the largest market, increasing from approximately USD 4.20 billion in 2025 to USD 10.80 billion by 2035. The West is expected to be the fastest-growing region, rising from approximately USD 2.79 billion to USD 7.64 billion. The Northeast will remain strategically valuable for advanced technology adoption, while the Midwest will provide stable institutional and chronic-disease testing demand.

For manufacturers, investors, distributors, and healthcare buyers evaluating the U.S. Disposable Point-of-Care Testing Devices Market, the central strategic question is no longer whether testing will move closer to patients. That transition is already underway. The more important questions are which tests generate enough clinical value to justify decentralized economics, which disposable formats can replace or complement central-laboratory workflows, which applications can successfully migrate into the home, and which companies can translate instrument placements or consumer adoption into durable recurring consumable revenue.

Over the next decade, market leadership will belong to companies that combine analytical performance, workflow simplicity, menu expansion, regulatory execution, manufacturing resilience, digital connectivity, and compelling cost-per-clinical-decision economics.

 

TABLE OF CONTENT

1. U.S. Disposable Point-of-Care Testing Devices Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Analytical Frameworks & Forecasting Models
1.3.6. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Disposable Point-of-Care Test Manufacturers
1.6.2. Diagnostic Reagent, Biosensor, Membrane and Microfluidic Component Suppliers
1.6.3. Contract Manufacturing and Packaging Partners
1.6.4. Hospitals and Integrated Delivery Networks
1.6.5. Physician Offices, Urgent-Care Centers and Ambulatory Providers
1.6.6. Retail Pharmacies, Community Health Providers and Home-Testing Channels
1.6.7. Group Purchasing Organizations, Diagnostic Distributors and Wholesalers
1.6.8. Payers, FDA, CMS, CLIA Authorities and Public Health Agencies

What this section provides: This section defines the market boundary for disposable point-of-care testing devices, establishes inclusion and exclusion criteria, explains the research and forecasting methodology, and maps the stakeholder ecosystem influencing U.S. test utilization and purchasing.

2. U.S. Disposable Point-of-Care Testing Devices Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. Market Size, Growth and CAGR Assessment
2.8. Recurring Consumables Revenue Opportunity
2.9. High-Growth Opportunity Areas
2.10. Leading and Fastest-Growing Segments
2.11. Key Regional and State-Level Opportunity Hotspots

What this section provides: This section gives decision-makers a concise view of U.S. market size, historical development, forecast growth, recurring-consumable economics, leading segments, competitive intensity, and priority investment opportunities through 2035.

3. U.S. Disposable Point-of-Care Testing Devices Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Rising Diabetes and Chronic Disease Testing Burden
3.1.2. Expansion of Decentralized Infectious Disease Testing
3.1.3. Growing Adoption of CLIA-Waived Point-of-Care Tests
3.1.4. Expansion of At-Home and Self-Testing
3.1.5. Need for Faster Emergency and Acute-Care Clinical Decisions
3.1.6. Recurring Demand for Single-Use Testing Consumables
3.1.7. Growth of Urgent-Care and Retail Health Testing
3.1.8. Increasing Demand for Multiplex Respiratory Diagnostics
3.2. Restraints and Their Impact Analysis
3.2.1. Per-Test Cost Premium Versus Central Laboratory Testing
3.2.2. Reimbursement and Coverage Variability
3.2.3. Test Accuracy and User-Error Concerns in Decentralized Settings
3.2.4. Pricing Pressure in Mature Lateral-Flow and Glucose Strip Categories
3.2.5. Waste Generation Associated with Single-Use Diagnostic Products
3.2.6. Regulatory Transition and Evidence Requirements
3.3. Opportunities and Their Impact Analysis
3.3.1. Disposable Molecular Point-of-Care Testing
3.3.2. Multiplex Flu, COVID-19 and RSV Testing
3.3.3. At-Home Sexual Health Diagnostics
3.3.4. Renal and Chronic Disease Screening at Point of Care
3.3.5. Connected and Digitally Interpreted Disposable Tests
3.3.6. Rural and Underserved Population Testing
3.3.7. Pharmacy-Based Diagnostic Services
3.3.8. New CLIA-Waived Diagnostic Menus
3.4. Challenges and Their Impact Analysis
3.4.1. Maintaining Lot-to-Lot Analytical Consistency
3.4.2. Supply Chain Dependence for Reagents and Diagnostic Components
3.4.3. Managing Seasonal Demand Volatility
3.4.4. Ensuring User Compliance with Test Instructions
3.4.5. Integration of Decentralized Results into Clinical Records
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Clinical Workflow Economics Analysis
3.7. Cost-per-Actionable-Result Analysis
3.8. Recurring Consumables and Installed-Base Economics
3.9. Health System Consumables Procurement & Formulary Behavior Analysis
3.10. Point-of-Care Versus Central Laboratory Workflow Comparison

What this section provides: This section explains the clinical, operational, reimbursement, technological and commercial forces shaping disposable POC testing demand and helps clients evaluate growth catalysts, adoption barriers and execution risks.

4. U.S. Disposable Point-of-Care Testing Devices Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Substitution Risk
4.2.5. Competitive Rivalry
4.3. Pricing Trend Analysis by Region, 2025–2035
4.4. Average Selling Price Analysis by Disposable Test Format
4.5. Value Chain & Supply Chain Analysis
4.6. Diagnostic Reagent and Component Supply Analysis
4.7. Contract Manufacturing and Private-Label Landscape
4.8. Impact of Digitalization and Connected Point-of-Care Testing
4.9. Application & Innovation Landscape
4.10. FDA Regulatory Framework Analysis
4.11. CLIA-Waived Testing Regulatory Landscape
4.12. OTC and Home-Use Diagnostic Authorization Landscape
4.13. CMS Reimbursement and Coverage Landscape
4.14. CPT Coding and Diagnostic Payment Considerations
4.15. Import/Export Restrictions & Tariff Impact
4.16. U.S. Domestic Diagnostic Manufacturing Landscape
4.17. Government Initiatives and Public Health Testing Programs
4.18. Impact of Escalating Geopolitical and Supply-Chain Tensions
4.19. Hospital Value Analysis and Laboratory Committee Decision Framework
4.20. Diagnostic Distributor and GPO Contracting Environment
4.21. Environmental Impact of Disposable Diagnostic Waste

What this section provides: This section gives clients a comprehensive view of regulation, CLIA-waiver pathways, reimbursement, pricing, manufacturing, supply chains, procurement, digital connectivity and competitive conditions affecting disposable point-of-care testing in the United States.

5. U.S. Disposable Point-of-Care Testing Devices Market – By Product Format

5.1. Overview
5.1.1. Segment Share Analysis, By Product Format, 2025 & 2035 (%)
5.1.2. Test Strips and Dipsticks
5.1.2.1. Blood Glucose Test Strips
5.1.2.2. Urinalysis Strips
5.1.2.3. Ketone Test Strips
5.1.2.4. Coagulation-Related Test Strips
5.1.2.5. Other Diagnostic Strips
5.1.3. Disposable Cartridges and Cassettes
5.1.3.1. Blood Gas and Electrolyte Cartridges
5.1.3.2. Cardiac Marker Cartridges
5.1.3.3. Coagulation Cartridges
5.1.3.4. Immunoassay Cassettes
5.1.3.5. Molecular Diagnostic Cartridges
5.1.4. Lateral-Flow Cards and Rapid Test Kits
5.1.4.1. Respiratory Rapid Tests
5.1.4.2. Pregnancy and Fertility Tests
5.1.4.3. HIV and STI Rapid Tests
5.1.4.4. Strep and Other Infectious Disease Tests
5.1.4.5. Drugs-of-Abuse Rapid Tests
5.1.5. Collection-Integrated Disposable Devices
5.1.5.1. Swab-Integrated Test Devices
5.1.5.2. Capillary Blood Collection-Integrated Tests
5.1.5.3. Specimen Cup and Collection-Integrated Devices
5.1.5.4. Closed Sample-to-Result Devices
5.1.6. Single-Use Microfluidic and Molecular Devices
5.1.6.1. Integrated PCR Devices
5.1.6.2. Isothermal Amplification Devices
5.1.6.3. Disposable Microfluidic Diagnostic Platforms
5.1.6.4. Fully Integrated Single-Use Molecular Tests

What this section provides: This section identifies which disposable device formats generate the largest recurring revenue pools and which next-generation cartridge, microfluidic and molecular formats are expected to record the strongest growth through 2035.

6. U.S. Disposable Point-of-Care Testing Devices Market – By Application

6.1. Overview
6.1.1. Segment Share Analysis, By Application, 2025 & 2035 (%)
6.1.2. Diabetes and Metabolic Monitoring
6.1.2.1. Blood Glucose Testing
6.1.2.2. Ketone Testing
6.1.2.3. HbA1c Point-of-Care Testing
6.1.2.4. Metabolic and Renal Risk Screening
6.1.3. Infectious Disease Testing
6.1.3.1. COVID-19 Testing
6.1.3.2. Influenza Testing
6.1.3.3. RSV Testing
6.1.3.4. Multiplex Respiratory Testing
6.1.3.5. Group A Streptococcus Testing
6.1.3.6. HIV Testing
6.1.3.7. Sexually Transmitted Infection Testing
6.1.3.8. Other Infectious Disease Testing
6.1.4. Pregnancy and Fertility Testing
6.1.4.1. Pregnancy Testing
6.1.4.2. Ovulation and Fertility Testing
6.1.5. Cardiac, Coagulation and Critical-Care Testing
6.1.5.1. Cardiac Marker Testing
6.1.5.2. Coagulation Testing
6.1.5.3. Blood Gas and Electrolyte Testing
6.1.5.4. Lactate and Critical-Care Testing
6.1.6. Drugs-of-Abuse, Renal, Urinalysis and Other Applications
6.1.6.1. Drugs-of-Abuse Testing
6.1.6.2. Urinalysis
6.1.6.3. Renal Screening
6.1.6.4. Lipid and Cholesterol Testing
6.1.6.5. Gastrointestinal and Fecal Testing
6.1.6.6. Other Point-of-Care Applications

What this section provides: This section enables clients to compare disposable POC demand across major clinical applications and identify disease areas where testing frequency, immediate treatment decisions and decentralization create the strongest commercial opportunities.

7. U.S. Disposable Point-of-Care Testing Devices Market – By Sample Type

7.1. Overview
7.1.1. Segment Share Analysis, By Sample Type, 2025 & 2035 (%)
7.1.2. Capillary and Whole Blood
7.1.2.1. Fingerstick Capillary Blood
7.1.2.2. Venous Whole Blood
7.1.2.3. Arterial Whole Blood
7.1.3. Nasal and Nasopharyngeal Samples
7.1.3.1. Anterior Nasal Samples
7.1.3.2. Nasopharyngeal Samples
7.1.3.3. Combined Respiratory Specimens
7.1.4. Urine
7.1.4.1. Pregnancy and Fertility Samples
7.1.4.2. Routine Urinalysis Samples
7.1.4.3. Drugs-of-Abuse Samples
7.1.4.4. Renal and Metabolic Screening Samples
7.1.5. Saliva and Oral Fluid
7.1.5.1. Oral Fluid Infectious Disease Testing
7.1.5.2. Saliva-Based Molecular Testing
7.1.5.3. Oral Fluid Drugs-of-Abuse Testing
7.1.6. Other Specimens
7.1.6.1. Vaginal and Genital Swabs
7.1.6.2. Throat Swabs
7.1.6.3. Stool Samples
7.1.6.4. Wound and Other Application-Specific Specimens

What this section provides: This section evaluates revenue and adoption by specimen type, helping clients understand how sample accessibility, invasiveness, collection complexity and clinical application influence disposable testing demand.

8. U.S. Disposable Point-of-Care Testing Devices Market – By End User

8.1. Overview
8.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
8.1.2. Hospitals and Health Systems
8.1.2.1. Emergency Departments
8.1.2.2. Intensive and Critical-Care Units
8.1.2.3. Inpatient Departments
8.1.2.4. Hospital Outpatient Departments
8.1.2.5. Labor and Delivery Units
8.1.3. Physician Offices and Urgent-Care Centers
8.1.3.1. Primary Care Practices
8.1.3.2. Specialty Physician Practices
8.1.3.3. Urgent-Care Centers
8.1.3.4. Walk-In Medical Clinics
8.1.4. Home and Self-Testing
8.1.4.1. Chronic Disease Self-Testing
8.1.4.2. Infectious Disease Self-Testing
8.1.4.3. Pregnancy and Fertility Self-Testing
8.1.4.4. Sexual Health Self-Testing
8.1.5. Retail Pharmacies and Community Health Settings
8.1.5.1. Retail Pharmacies
8.1.5.2. Community Health Centers
8.1.5.3. Public Health Clinics
8.1.5.4. Mobile and Outreach Testing Programs
8.1.6. Ambulatory, Post-Acute, Employer and Other Settings
8.1.6.1. Ambulatory Surgery Centers
8.1.6.2. Skilled Nursing and Long-Term Care Facilities
8.1.6.3. Home Healthcare Providers
8.1.6.4. Employer and Occupational Health Programs
8.1.6.5. Emergency Medical Services
8.1.6.6. Schools, Correctional Facilities and Other Institutional Users

What this section provides: This section identifies the customer groups generating disposable test demand and evaluates the migration of diagnostic testing from hospitals toward urgent care, physician offices, pharmacies, homes and other decentralized settings.

9. U.S. Disposable Point-of-Care Testing Devices Market – By Technology Type

9.1. Overview
9.1.1. Segment Share Analysis, By Technology Type, 2025 & 2035 (%)
9.1.2. Electrochemical and Biosensor-Based Testing
9.1.2.1. Enzymatic Electrochemical Biosensors
9.1.2.2. Multi-Analyte Biosensor Cartridges
9.1.2.3. Disposable Sensor-Based Test Strips
9.1.3. Lateral-Flow Immunoassays
9.1.3.1. Visual Lateral-Flow Tests
9.1.3.2. Reader-Assisted Lateral-Flow Tests
9.1.3.3. Multiplex Lateral-Flow Tests
9.1.4. Instrument-Read Immunofluorescence and Immunoassays
9.1.4.1. Fluorescence Immunoassays
9.1.4.2. Optical Reader-Based Immunoassays
9.1.4.3. Quantitative Disposable Immunoassay Cassettes
9.1.5. Molecular Cartridge and Integrated Nucleic-Acid Testing
9.1.5.1. PCR-Based Disposable Cartridges
9.1.5.2. Isothermal Molecular Tests
9.1.5.3. Multiplex Molecular Cartridges
9.1.5.4. Fully Disposable Molecular Platforms
9.1.6. Dry Chemistry, Microfluidics and Other Disposable Technologies
9.1.6.1. Dry Chemistry
9.1.6.2. Microfluidic Platforms
9.1.6.3. Optical and Colorimetric Detection
9.1.6.4. Other Emerging Disposable Detection Technologies

What this section provides: This section evaluates the diagnostic technologies competing within disposable POC testing and identifies how biosensors, immunoassays, molecular cartridges and microfluidics are reshaping performance, pricing and addressable applications.

10. U.S. Disposable Point-of-Care Testing Devices Market – By Geography

10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Disposable Test Utilization Analysis
10.1.4. Regional Hospital, Urgent-Care and Retail Testing Infrastructure Analysis
10.1.5. Regional Chronic and Infectious Disease Burden Analysis
10.1.6. Regional CLIA-Waived Testing Penetration
10.1.7. Regional Reimbursement and Procurement Dynamics
10.1.8. State-Level Commercial Opportunity Index
10.2. West Region
10.2.1. Regional Overview & Trends
10.2.2. West Region Key Manufacturers, Distributors and Testing Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.9. California
10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.10. Washington
10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.11. Arizona
10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.12. Colorado
10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.13. Oregon
10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.14. Utah
10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.15. Nevada
10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.16. New Mexico
10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.17. Idaho
10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.18. Montana
10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.19. Wyoming
10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.20. Alaska
10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.21. Hawaii
10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3. Northeast Region
10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Key Manufacturers, Distributors and Testing Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.9. New York
10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.10. Massachusetts
10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.11. New Jersey
10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.12. Pennsylvania
10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.13. Connecticut
10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.14. Maine
10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.15. Vermont
10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.16. New Hampshire
10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.17. Rhode Island
10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.18. Delaware
10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4. South Region
10.4.1. Regional Overview & Trends
10.4.2. South Region Key Manufacturers, Distributors and Testing Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.9. Texas
10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.10. Florida
10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.11. Georgia
10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.12. North Carolina
10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.13. Tennessee
10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.14. South Carolina
10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.15. Alabama
10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.16. Mississippi
10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.17. Louisiana
10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.18. Arkansas
10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.19. Kentucky
10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.20. Oklahoma
10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.21. Virginia
10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.22. Maryland
10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.23. West Virginia
10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5. Midwest Region
10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Key Manufacturers, Distributors and Testing Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.9. Illinois
10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.10. Ohio
10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.11. Michigan
10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.12. Minnesota
10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.13. Indiana
10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.14. Wisconsin
10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.15. Missouri
10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.16. Iowa
10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.17. Kansas
10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.18. Nebraska
10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.19. North Dakota
10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.20. South Dakota
10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Product Format, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By Sample Type, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

What this section provides: This section delivers detailed regional and state-level market intelligence across all 50 U.S. states, enabling clients to identify high-volume testing markets, chronic and infectious disease demand pockets, decentralized-care opportunities, adoption hotspots and state-level commercial priorities.

11. U.S. Disposable Point-of-Care Testing Devices Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.2. Competitive Benchmarking Analysis
11.3. Company Positioning Matrix
11.3.1. Leaders
11.3.2. Challengers
11.3.3. Innovators
11.3.4. Emerging Players
11.4. Competitive Assessment by Product Portfolio
11.5. Competitive Assessment by Installed Base and Consumables Revenue
11.6. Competitive Assessment by CLIA-Waived and OTC Portfolio
11.7. Competitive Assessment by Molecular and Multiplex Capabilities
11.8. Company Profiles
11.8.1. Abbott Laboratories
11.8.2. Roche Diagnostics
11.8.3. Danaher Corporation – Cepheid
11.8.4. QuidelOrtho Corporation
11.8.5. Becton, Dickinson and Company
11.8.6. Siemens Healthineers
11.8.7. bioMérieux
11.8.8. Hologic, Inc.
11.8.9. Thermo Fisher Scientific Inc.
11.8.10. QIAGEN N.V.
11.8.11. Bio-Rad Laboratories, Inc.
11.8.12. Nova Biomedical
11.8.13. EKF Diagnostics Holdings plc
11.8.14. OraSure Technologies, Inc.
11.8.15. Trinity Biotech plc
11.8.16. Sekisui Diagnostics
11.8.17. ACON Laboratories, Inc.
11.8.18. iHealth Labs Inc.
11.8.19. Access Bio, Inc.
11.8.20. InBios International, Inc.
11.8.21. Visby Medical, Inc.
11.8.22. binx health
11.8.23. PTS Diagnostics
11.8.24. ARKRAY USA, Inc.
11.8.25. Werfen
11.9. Company Profile Framework
11.9.1. Company Overview
11.9.2. Disposable POC Testing Product Portfolio
11.9.3. U.S. Market Strategy
11.9.4. Financial and Commercial Positioning
11.9.5. Installed Base and Recurring Consumables Strategy
11.9.6. FDA, CLIA-Waived and OTC Regulatory Positioning
11.9.7. Product Pipeline and Innovation Focus
11.9.8. Partnerships, Distribution and Strategic Alliances
11.9.9. Recent Developments

What this section provides: This section gives clients competitor benchmarking, market-share visibility, installed-base intelligence, consumables positioning, regulatory capabilities, innovation direction and strategic analysis of 25 major companies competing in the U.S. disposable POC testing ecosystem.

12. U.S. Disposable Point-of-Care Testing Devices Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario
12.2. Disruptive Technologies Impact
12.2.1. Fully Disposable Molecular Diagnostic Platforms
12.2.2. Multiplex Respiratory Testing
12.2.3. Microfluidic Sample-to-Answer Systems
12.2.4. Next-Generation Electrochemical Biosensors
12.2.5. Digitally Interpreted Lateral-Flow Tests
12.2.6. Smartphone-Connected Home Diagnostics
12.2.7. AI-Assisted Test Interpretation and Clinical Decision Support
12.3. Evolution of At-Home Diagnostic Testing
12.4. Future of CLIA-Waived Molecular Testing
12.5. Transition from Single-Analyte to Multiplex Testing
12.6. Future of Instrument-Free Disposable Diagnostics
12.7. Future Recurring Consumables Business Models
12.8. Emerging Business Trends
12.9. Business Opportunities for Startups and Existing Players
12.10. Investment Prioritization Matrix
12.11. High-Growth Application Opportunity Matrix
12.12. State and Regional Expansion Opportunity Matrix

What this section provides: This section prepares clients for future diagnostic technology shifts, home-testing expansion, molecular decentralization, changing business models and investment opportunities expected to influence the U.S. disposable POC testing market through 2035.

13. U.S. Disposable Point-of-Care Testing Devices Market: Strategic Recommendations

13.1. Recommendations for Disposable Diagnostic Device Manufacturers
13.2. Recommendations for Hospitals and Health Systems
13.3. Recommendations for Physician Offices and Urgent-Care Networks
13.4. Recommendations for Retail Pharmacy and Home-Testing Companies
13.5. Recommendations for Investors and Private Equity Firms
13.6. Recommendations for Diagnostic Distributors and Channel Partners
13.7. Recommendations for New Entrants and Startups
13.8. U.S. Go-to-Market Strategy Considerations
13.9. CLIA-Waiver and OTC Commercialization Strategy
13.10. Product Positioning and Portfolio Expansion Guidance
13.11. Analyzer Placement and Recurring Consumables Strategy
13.12. Pricing and Contracting Strategy
13.13. Regional and State-Level Market Entry Prioritization
13.14. Partnerships, Licensing and M&A Opportunity Assessment

What this section provides: This section converts the market intelligence into actionable strategy for product development, commercialization, regulatory positioning, recurring consumables growth, channel expansion, geographic prioritization, investment and competitive differentiation.

14. U.S. Disposable Point-of-Care Testing Devices Market: Disclaimer

14.1. Scope Limitation
14.2. Data Use Limitation
14.3. Market Estimation Limitation
14.4. Forecasting Limitation
14.5. State-Level Estimation Limitation
14.6. Legal Disclaimer
14.7. Third-Party Data Disclaimer

What this section provides: This section clarifies the report’s scope, methodological boundaries, market-estimation limitations, state-level modeling considerations, legal terms, third-party data usage and forecast assumptions.

 

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Disposable Point-of-Care Testing Devices Market: Market Definition and Scope
TABLE 3: U.S. Disposable Point-of-Care Testing Devices Market: Research Methodology Framework
TABLE 4: U.S. Disposable Point-of-Care Testing Devices Market: Key Assumptions
TABLE 5: U.S. Disposable Point-of-Care Testing Devices Market: Market Ecosystem Overview
TABLE 6: U.S. Disposable Point-of-Care Testing Devices Market: Stakeholder Analysis
TABLE 7: U.S. Disposable Point-of-Care Testing Devices Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Disposable Point-of-Care Testing Devices Market: Analyst Viewpoint Summary
TABLE 9: U.S. Disposable Point-of-Care Testing Devices Market: Market Attractiveness Index
TABLE 10: U.S. Disposable Point-of-Care Testing Devices Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Disposable Point-of-Care Testing Devices Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 12: U.S. Disposable Point-of-Care Testing Devices Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 13: U.S. Disposable Point-of-Care Testing Devices Market: Drivers; Impact Analysis
TABLE 14: U.S. Disposable Point-of-Care Testing Devices Market: Restraints; Impact Analysis
TABLE 15: U.S. Disposable Point-of-Care Testing Devices Market: Opportunities; Impact Analysis
TABLE 16: U.S. Disposable Point-of-Care Testing Devices Market: Challenges; Impact Analysis
TABLE 17: U.S. Disposable Point-of-Care Testing Devices Market: Patent & Innovation Analysis, 2021–2025
TABLE 18: U.S. Disposable Point-of-Care Testing Devices Market: Clinical Workflow Economics Matrix
TABLE 19: U.S. Disposable Point-of-Care Testing Devices Market: Recurring Consumables and Procurement Economics Matrix
TABLE 20: U.S. Disposable Point-of-Care Testing Devices Market: PESTEL Analysis
TABLE 21: U.S. Disposable Point-of-Care Testing Devices Market: Porter’s Five Forces Analysis
TABLE 22: U.S. Disposable Point-of-Care Testing Devices Market: Pricing Trend Analysis by Region, 2025–2035
TABLE 23: U.S. Disposable Point-of-Care Testing Devices Market: Value Chain Analysis
TABLE 24: U.S. Disposable Point-of-Care Testing Devices Market: Supply Chain Analysis
TABLE 25: U.S. Disposable Point-of-Care Testing Devices Market: Digitalization and Connected POC Testing Impact
TABLE 26: U.S. Disposable Point-of-Care Testing Devices Market: Application & Innovation Landscape
TABLE 27: U.S. Disposable Point-of-Care Testing Devices Market: FDA Regulatory Framework Analysis
TABLE 28: U.S. Disposable Point-of-Care Testing Devices Market: CLIA-Waived, OTC and Home-Use Testing Landscape
TABLE 29: U.S. Disposable Point-of-Care Testing Devices Market: CMS Reimbursement and Coverage Landscape
TABLE 30: U.S. Disposable Point-of-Care Testing Devices Market: Import/Export Restrictions & Tariff Impact
TABLE 31: U.S. Disposable Point-of-Care Testing Devices Market: Government Initiatives and Public Health Testing Programs
TABLE 32: U.S. Disposable Point-of-Care Testing Devices Market: Hospital Value Analysis and Diagnostic Procurement Framework
TABLE 33: U.S. Disposable Point-of-Care Testing Devices Market: Product Format Snapshot, 2025
TABLE 34: Segment Dashboard; Definition and Scope, by Product Format
TABLE 35: U.S. Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 36: U.S. Disposable Point-of-Care Testing Devices Market: Segment Share Analysis, by Product Format, 2025 & 2035 (%)
TABLE 37: U.S. Disposable Point-of-Care Testing Devices Market: Test Strips and Dipsticks Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 38: U.S. Disposable Point-of-Care Testing Devices Market: Disposable Cartridges and Cassettes Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 39: U.S. Disposable Point-of-Care Testing Devices Market: Lateral-Flow Cards and Rapid Test Kits Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 40: U.S. Disposable Point-of-Care Testing Devices Market: Collection-Integrated Disposable Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 41: U.S. Disposable Point-of-Care Testing Devices Market: Single-Use Microfluidic and Molecular Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 42: U.S. Disposable Point-of-Care Testing Devices Market: Application Snapshot, 2025
TABLE 43: Segment Dashboard; Definition and Scope, by Application
TABLE 44: U.S. Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 45: U.S. Disposable Point-of-Care Testing Devices Market: Segment Share Analysis, by Application, 2025 & 2035 (%)
TABLE 46: U.S. Disposable Point-of-Care Testing Devices Market: Diabetes and Metabolic Monitoring Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 47: U.S. Disposable Point-of-Care Testing Devices Market: Infectious Disease Testing Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 48: U.S. Disposable Point-of-Care Testing Devices Market: Pregnancy and Fertility Testing Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 49: U.S. Disposable Point-of-Care Testing Devices Market: Cardiac, Coagulation and Critical-Care Testing Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 50: U.S. Disposable Point-of-Care Testing Devices Market: Drugs-of-Abuse, Renal, Urinalysis and Other Applications Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 51: U.S. Disposable Point-of-Care Testing Devices Market: Sample Type Snapshot, 2025
TABLE 52: Segment Dashboard; Definition and Scope, by Sample Type
TABLE 53: U.S. Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 54: U.S. Disposable Point-of-Care Testing Devices Market: Segment Share Analysis, by Sample Type, 2025 & 2035 (%)
TABLE 55: U.S. Disposable Point-of-Care Testing Devices Market: Capillary and Whole Blood Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 56: U.S. Disposable Point-of-Care Testing Devices Market: Nasal and Nasopharyngeal Samples Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 57: U.S. Disposable Point-of-Care Testing Devices Market: Urine Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 58: U.S. Disposable Point-of-Care Testing Devices Market: Saliva and Oral Fluid Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 59: U.S. Disposable Point-of-Care Testing Devices Market: Other Specimens Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 60: U.S. Disposable Point-of-Care Testing Devices Market: End User Snapshot, 2025
TABLE 61: Segment Dashboard; Definition and Scope, by End User
TABLE 62: U.S. Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 63: U.S. Disposable Point-of-Care Testing Devices Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 64: U.S. Disposable Point-of-Care Testing Devices Market: Hospitals and Health Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 65: U.S. Disposable Point-of-Care Testing Devices Market: Physician Offices and Urgent-Care Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 66: U.S. Disposable Point-of-Care Testing Devices Market: Home and Self-Testing Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 67: U.S. Disposable Point-of-Care Testing Devices Market: Retail Pharmacies and Community Health Settings Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 68: U.S. Disposable Point-of-Care Testing Devices Market: Ambulatory, Post-Acute, Employer and Other Settings Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 69: U.S. Disposable Point-of-Care Testing Devices Market: Technology Type Snapshot, 2025
TABLE 70: Segment Dashboard; Definition and Scope, by Technology Type
TABLE 71: U.S. Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 72: U.S. Disposable Point-of-Care Testing Devices Market: Segment Share Analysis, by Technology Type, 2025 & 2035 (%)
TABLE 73: U.S. Disposable Point-of-Care Testing Devices Market: Electrochemical and Biosensor-Based Testing Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 74: U.S. Disposable Point-of-Care Testing Devices Market: Lateral-Flow Immunoassays Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 75: U.S. Disposable Point-of-Care Testing Devices Market: Instrument-Read Immunofluorescence and Immunoassays Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 76: U.S. Disposable Point-of-Care Testing Devices Market: Molecular Cartridge and Integrated Nucleic-Acid Testing Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 77: U.S. Disposable Point-of-Care Testing Devices Market: Dry Chemistry, Microfluidics and Other Disposable Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 78: U.S. Disposable Point-of-Care Testing Devices Market: Regional Snapshot, 2025
TABLE 79: Segment Dashboard; Definition and Scope, by Region
TABLE 80: U.S. Disposable Point-of-Care Testing Devices Market, by Region, 2021–2035 (US$ Billion)
TABLE 81: U.S. Disposable Point-of-Care Testing Devices Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 82: West Region U.S. Disposable Point-of-Care Testing Devices Market: Regional Overview and Trends
TABLE 83: West Region U.S. Disposable Point-of-Care Testing Devices Market: Key Manufacturers and Testing Ecosystem
TABLE 84: West Region U.S. Disposable Point-of-Care Testing Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 85: West Region U.S. Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 86: West Region U.S. Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 87: West Region U.S. Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 88: West Region U.S. Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 89: West Region U.S. Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 90: California Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 91: California Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 92: California Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 93: California Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 94: California Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 95: Washington Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 96: Washington Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 97: Washington Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 98: Washington Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 99: Washington Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 100: Arizona Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 101: Arizona Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 102: Arizona Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 103: Arizona Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 104: Arizona Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 105: Colorado Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 106: Colorado Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 107: Colorado Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 108: Colorado Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 109: Colorado Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 110: Oregon Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 111: Oregon Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 112: Oregon Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 113: Oregon Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 114: Oregon Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 115: Utah Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 116: Utah Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 117: Utah Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 118: Utah Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 119: Utah Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 120: Nevada Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 121: Nevada Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 122: Nevada Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 123: Nevada Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 124: Nevada Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 125: New Mexico Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 126: New Mexico Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 127: New Mexico Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 128: New Mexico Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 129: New Mexico Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 130: Idaho Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 131: Idaho Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 132: Idaho Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 133: Idaho Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 134: Idaho Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 135: Montana Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 136: Montana Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 137: Montana Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 138: Montana Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 139: Montana Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 140: Wyoming Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 141: Wyoming Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 142: Wyoming Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 143: Wyoming Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 144: Wyoming Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 145: Alaska Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 146: Alaska Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 147: Alaska Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 148: Alaska Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 149: Alaska Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 150: Hawaii Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 151: Hawaii Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 152: Hawaii Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 153: Hawaii Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 154: Hawaii Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 155: Northeast Region U.S. Disposable Point-of-Care Testing Devices Market: Regional Overview and Trends
TABLE 156: Northeast Region U.S. Disposable Point-of-Care Testing Devices Market: Key Manufacturers and Testing Ecosystem
TABLE 157: Northeast Region U.S. Disposable Point-of-Care Testing Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 158: Northeast Region U.S. Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 159: Northeast Region U.S. Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 160: Northeast Region U.S. Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 161: Northeast Region U.S. Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 162: Northeast Region U.S. Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 163: New York Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 164: New York Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 165: New York Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 166: New York Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 167: New York Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 168: Massachusetts Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 169: Massachusetts Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 170: Massachusetts Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 171: Massachusetts Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 172: Massachusetts Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 173: New Jersey Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 174: New Jersey Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 175: New Jersey Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 176: New Jersey Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 177: New Jersey Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 178: Pennsylvania Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 179: Pennsylvania Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 180: Pennsylvania Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 181: Pennsylvania Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 182: Pennsylvania Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 183: Connecticut Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 184: Connecticut Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 185: Connecticut Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 186: Connecticut Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 187: Connecticut Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 188: Maine Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 189: Maine Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 190: Maine Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 191: Maine Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 192: Maine Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 193: Vermont Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 194: Vermont Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 195: Vermont Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 196: Vermont Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 197: Vermont Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 198: New Hampshire Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 199: New Hampshire Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 200: New Hampshire Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 201: New Hampshire Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 202: New Hampshire Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 203: Rhode Island Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 204: Rhode Island Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 205: Rhode Island Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 206: Rhode Island Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 207: Rhode Island Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 208: Delaware Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 209: Delaware Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 210: Delaware Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 211: Delaware Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 212: Delaware Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 213: South Region U.S. Disposable Point-of-Care Testing Devices Market: Regional Overview and Trends
TABLE 214: South Region U.S. Disposable Point-of-Care Testing Devices Market: Key Manufacturers and Testing Ecosystem
TABLE 215: South Region U.S. Disposable Point-of-Care Testing Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 216: South Region U.S. Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 217: South Region U.S. Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 218: South Region U.S. Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 219: South Region U.S. Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 220: South Region U.S. Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 221: Texas Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 222: Texas Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 223: Texas Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 224: Texas Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 225: Texas Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 226: Florida Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 227: Florida Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 228: Florida Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 229: Florida Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 230: Florida Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 231: Georgia Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 232: Georgia Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 233: Georgia Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 234: Georgia Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 235: Georgia Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 236: North Carolina Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 237: North Carolina Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 238: North Carolina Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 239: North Carolina Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 240: North Carolina Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 241: Tennessee Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 242: Tennessee Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 243: Tennessee Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 244: Tennessee Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 245: Tennessee Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 246: South Carolina Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 247: South Carolina Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 248: South Carolina Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 249: South Carolina Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 250: South Carolina Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 251: Alabama Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 252: Alabama Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 253: Alabama Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 254: Alabama Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 255: Alabama Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 256: Mississippi Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 257: Mississippi Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 258: Mississippi Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 259: Mississippi Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 260: Mississippi Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 261: Louisiana Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 262: Louisiana Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 263: Louisiana Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 264: Louisiana Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 265: Louisiana Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 266: Arkansas Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 267: Arkansas Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 268: Arkansas Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 269: Arkansas Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 270: Arkansas Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 271: Kentucky Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 272: Kentucky Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 273: Kentucky Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 274: Kentucky Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 275: Kentucky Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 276: Oklahoma Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 277: Oklahoma Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 278: Oklahoma Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 279: Oklahoma Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 280: Oklahoma Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 281: Virginia Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 282: Virginia Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 283: Virginia Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 284: Virginia Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 285: Virginia Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 286: Maryland Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 287: Maryland Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 288: Maryland Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 289: Maryland Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 290: Maryland Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 291: West Virginia Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 292: West Virginia Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 293: West Virginia Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 294: West Virginia Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 295: West Virginia Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 296: Midwest Region U.S. Disposable Point-of-Care Testing Devices Market: Regional Overview and Trends
TABLE 297: Midwest Region U.S. Disposable Point-of-Care Testing Devices Market: Key Manufacturers and Testing Ecosystem
TABLE 298: Midwest Region U.S. Disposable Point-of-Care Testing Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 299: Midwest Region U.S. Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 300: Midwest Region U.S. Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 301: Midwest Region U.S. Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 302: Midwest Region U.S. Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 303: Midwest Region U.S. Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 304: Illinois Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 305: Illinois Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 306: Illinois Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 307: Illinois Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 308: Illinois Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 309: Ohio Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 310: Ohio Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 311: Ohio Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 312: Ohio Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 313: Ohio Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 314: Michigan Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 315: Michigan Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 316: Michigan Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 317: Michigan Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 318: Michigan Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 319: Minnesota Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 320: Minnesota Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 321: Minnesota Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 322: Minnesota Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 323: Minnesota Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 324: Indiana Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 325: Indiana Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 326: Indiana Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 327: Indiana Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 328: Indiana Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 329: Wisconsin Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 330: Wisconsin Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 331: Wisconsin Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 332: Wisconsin Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 333: Wisconsin Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 334: Missouri Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 335: Missouri Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 336: Missouri Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 337: Missouri Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 338: Missouri Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 339: Iowa Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 340: Iowa Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 341: Iowa Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 342: Iowa Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 343: Iowa Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 344: Kansas Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 345: Kansas Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 346: Kansas Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 347: Kansas Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 348: Kansas Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 349: Nebraska Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 350: Nebraska Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 351: Nebraska Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 352: Nebraska Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 353: Nebraska Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 354: North Dakota Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 355: North Dakota Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 356: North Dakota Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 357: North Dakota Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 358: North Dakota Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 359: South Dakota Disposable Point-of-Care Testing Devices Market, by Product Format, 2021–2035 (US$ Billion)
TABLE 360: South Dakota Disposable Point-of-Care Testing Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 361: South Dakota Disposable Point-of-Care Testing Devices Market, by Sample Type, 2021–2035 (US$ Billion)
TABLE 362: South Dakota Disposable Point-of-Care Testing Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 363: South Dakota Disposable Point-of-Care Testing Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 364: U.S. Disposable Point-of-Care Testing Devices Market: Competitive Landscape Snapshot, 2025
TABLE 365: U.S. Disposable Point-of-Care Testing Devices Market: Key Company Market Share Analysis, 2025
TABLE 366: U.S. Disposable Point-of-Care Testing Devices Market: Company Positioning Matrix
TABLE 367: U.S. Disposable Point-of-Care Testing Devices Market: Product, Installed-Base and Regulatory Portfolio Benchmarking
TABLE 368: U.S. Disposable Point-of-Care Testing Devices Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 369: Abbott Laboratories: Company Profile
TABLE 370: Roche Diagnostics: Company Profile
TABLE 371: Danaher Corporation – Cepheid: Company Profile
TABLE 372: QuidelOrtho Corporation: Company Profile
TABLE 373: Becton, Dickinson and Company: Company Profile
TABLE 374: Siemens Healthineers: Company Profile
TABLE 375: bioMérieux: Company Profile
TABLE 376: Hologic, Inc.: Company Profile
TABLE 377: Thermo Fisher Scientific Inc.: Company Profile
TABLE 378: QIAGEN N.V.: Company Profile
TABLE 379: Bio-Rad Laboratories, Inc.: Company Profile
TABLE 380: Nova Biomedical: Company Profile
TABLE 381: EKF Diagnostics Holdings plc: Company Profile
TABLE 382: OraSure Technologies, Inc.: Company Profile
TABLE 383: Trinity Biotech plc: Company Profile
TABLE 384: Sekisui Diagnostics: Company Profile
TABLE 385: ACON Laboratories, Inc.: Company Profile
TABLE 386: iHealth Labs Inc.: Company Profile
TABLE 387: Access Bio, Inc.: Company Profile
TABLE 388: InBios International, Inc.: Company Profile
TABLE 389: Visby Medical, Inc.: Company Profile
TABLE 390: binx health: Company Profile
TABLE 391: PTS Diagnostics: Company Profile
TABLE 392: ARKRAY USA, Inc.: Company Profile
TABLE 393: Werfen: Company Profile
TABLE 394: U.S. Disposable Point-of-Care Testing Devices Market: Future Market Scenario Analysis, 2026–2035
TABLE 395: U.S. Disposable Point-of-Care Testing Devices Market: Disruptive Technologies Impact Matrix
TABLE 396: U.S. Disposable Point-of-Care Testing Devices Market: Emerging Business Trends
TABLE 397: U.S. Disposable Point-of-Care Testing Devices Market: Business Opportunities for Startups and Existing Players
TABLE 398: U.S. Disposable Point-of-Care Testing Devices Market: Investment Prioritization Matrix
TABLE 399: U.S. Disposable Point-of-Care Testing Devices Market: Strategic Recommendations for Device Manufacturers
TABLE 400: U.S. Disposable Point-of-Care Testing Devices Market: Strategic Recommendations for Hospitals and Health Systems
TABLE 401: U.S. Disposable Point-of-Care Testing Devices Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 402: U.S. Disposable Point-of-Care Testing Devices Market: Strategic Recommendations for Distributors and Channel Partners
TABLE 403: U.S. Disposable Point-of-Care Testing Devices Market: Strategic Recommendations for New Entrants and Startups
TABLE 404: U.S. Disposable Point-of-Care Testing Devices Market: Go-to-Market, CLIA-Waiver and OTC Commercialization Strategy
TABLE 405: U.S. Disposable Point-of-Care Testing Devices Market: Product Positioning and Portfolio Expansion Guidance
TABLE 406: U.S. Disposable Point-of-Care Testing Devices Market: Scope Limitation
TABLE 407: U.S. Disposable Point-of-Care Testing Devices Market: Data Use Limitation
TABLE 408: U.S. Disposable Point-of-Care Testing Devices Market: Forecasting and State-Level Estimation Limitation
TABLE 409: U.S. Disposable Point-of-Care Testing Devices Market: Legal Disclaimer
TABLE 410: U.S. Disposable Point-of-Care Testing Devices Market: Third-Party Data Disclaimer

List of Figures

FIGURE 1: U.S. Disposable Point-of-Care Testing Devices Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Value Chain Analysis
FIGURE 4: Supply Chain Analysis
FIGURE 5: PESTEL Analysis
FIGURE 6: Porter’s Five Forces Analysis
FIGURE 7: Market Attractiveness Analysis
FIGURE 8: Market Dynamics
FIGURE 9: Innovation & Patent Landscape, 2021–2025
FIGURE 10: Clinical Workflow Economics Framework
FIGURE 11: Disposable Test Procurement and Recurring Consumables Economics Framework
FIGURE 12: U.S. Disposable Point-of-Care Testing Devices Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 13: U.S. Disposable Point-of-Care Testing Devices Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 14: U.S. Disposable Point-of-Care Testing Devices Market Year-wise Growth Curve, 2021–2035
FIGURE 15: Product Format Segment Market Share Analysis, 2025 & 2035
FIGURE 16: Product Format Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 17: Test Strips and Dipsticks Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 18: Disposable Cartridges and Cassettes Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 19: Lateral-Flow Cards and Rapid Test Kits Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 20: Collection-Integrated Disposable Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 21: Single-Use Microfluidic and Molecular Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 22: Application Segment Market Share Analysis, 2025 & 2035
FIGURE 23: Application Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 24: Diabetes and Metabolic Monitoring Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 25: Infectious Disease Testing Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 26: Pregnancy and Fertility Testing Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 27: Cardiac, Coagulation and Critical-Care Testing Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 28: Drugs-of-Abuse, Renal, Urinalysis and Other Applications Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 29: Sample Type Segment Market Share Analysis, 2025 & 2035
FIGURE 30: Sample Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 31: Capillary and Whole Blood Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 32: Nasal and Nasopharyngeal Samples Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 33: Urine Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 34: Saliva and Oral Fluid Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 35: Other Specimens Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 36: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 37: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 38: Hospitals and Health Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 39: Physician Offices and Urgent-Care Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 40: Home and Self-Testing Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 41: Retail Pharmacies and Community Health Settings Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 42: Ambulatory, Post-Acute, Employer and Other Settings Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 43: Technology Type Segment Market Share Analysis, 2025 & 2035
FIGURE 44: Technology Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 45: Electrochemical and Biosensor-Based Testing Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 46: Lateral-Flow Immunoassays Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 47: Instrument-Read Immunofluorescence and Immunoassays Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 48: Molecular Cartridge and Integrated Nucleic-Acid Testing Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 49: Dry Chemistry, Microfluidics and Other Disposable Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 50: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 51: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 52: West Region U.S. Disposable Point-of-Care Testing Devices Market Share and Leading Players, 2025
FIGURE 53: West Region Market Share Analysis by State, 2025
FIGURE 54: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 55: California Disposable Point-of-Care Testing Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 56: Washington Disposable Point-of-Care Testing Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 57: Arizona Disposable Point-of-Care Testing Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 58: Colorado Disposable Point-of-Care Testing Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 59: Oregon Disposable Point-of-Care Testing Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 60: Utah Disposable Point-of-Care Testing Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 61: Nevada Disposable Point-of-Care Testing Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 62: New Mexico Disposable Point-of-Care Testing Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 63: Idaho Disposable Point-of-Care Testing Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 64: Montana Disposable Point-of-Care Testing Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 65: Wyoming Disposable Point-of-Care Testing Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 66: Alaska Disposable Point-of-Care Testing Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 67: Hawaii Disposable Point-of-Care Testing Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 68: Northeast Region U.S. Disposable Point-of-Care Testing Devices Market Share and Leading Players, 2025
FIGURE 69: Northeast Region Market Share Analysis by State, 2025
FIGURE 70: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 71: New York Disposable Point-of-Care Testing Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 72: Massachusetts Disposable Point-of-Care Testing Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 73: New Jersey Disposable Point-of-Care Testing Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 74: Pennsylvania Disposable Point-of-Care Testing Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 75: Connecticut Disposable Point-of-Care Testing Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 76: Maine Disposable Point-of-Care Testing Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 77: Vermont Disposable Point-of-Care Testing Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 78: New Hampshire Disposable Point-of-Care Testing Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 79: Rhode Island Disposable Point-of-Care Testing Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 80: Delaware Disposable Point-of-Care Testing Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 81: South Region U.S. Disposable Point-of-Care Testing Devices Market Share and Leading Players, 2025
FIGURE 82: South Region Market Share Analysis by State, 2025
FIGURE 83: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 84: Texas Disposable Point-of-Care Testing Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 85: Florida Disposable Point-of-Care Testing Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 86: Georgia Disposable Point-of-Care Testing Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 87: North Carolina Disposable Point-of-Care Testing Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 88: Tennessee Disposable Point-of-Care Testing Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 89: South Carolina Disposable Point-of-Care Testing Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 90: Alabama Disposable Point-of-Care Testing Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 91: Mississippi Disposable Point-of-Care Testing Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 92: Louisiana Disposable Point-of-Care Testing Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 93: Arkansas Disposable Point-of-Care Testing Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 94: Kentucky Disposable Point-of-Care Testing Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 95: Oklahoma Disposable Point-of-Care Testing Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 96: Virginia Disposable Point-of-Care Testing Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 97: Maryland Disposable Point-of-Care Testing Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 98: West Virginia Disposable Point-of-Care Testing Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 99: Midwest Region U.S. Disposable Point-of-Care Testing Devices Market Share and Leading Players, 2025
FIGURE 100: Midwest Region Market Share Analysis by State, 2025
FIGURE 101: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 102: Illinois Disposable Point-of-Care Testing Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 103: Ohio Disposable Point-of-Care Testing Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 104: Michigan Disposable Point-of-Care Testing Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 105: Minnesota Disposable Point-of-Care Testing Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 106: Indiana Disposable Point-of-Care Testing Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 107: Wisconsin Disposable Point-of-Care Testing Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 108: Missouri Disposable Point-of-Care Testing Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 109: Iowa Disposable Point-of-Care Testing Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 110: Kansas Disposable Point-of-Care Testing Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 111: Nebraska Disposable Point-of-Care Testing Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 112: North Dakota Disposable Point-of-Care Testing Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 113: South Dakota Disposable Point-of-Care Testing Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 114: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 115: Company Positioning Matrix
FIGURE 116: Key Player Disposable POC Product and Regulatory Portfolio Benchmarking
FIGURE 117: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 118: Disposable Point-of-Care Testing Innovation Roadmap
FIGURE 119: Fully Disposable Molecular Diagnostics Adoption Roadmap
FIGURE 120: Multiplex Respiratory Testing Opportunity Map
FIGURE 121: At-Home and Connected Testing Growth Roadmap
FIGURE 122: Future Market Scenario Analysis, 2026–2035
FIGURE 123: Disruptive Technologies Impact Matrix
FIGURE 124: Emerging Business Trends Matrix
FIGURE 125: Investment Prioritization Matrix
FIGURE 126: Strategic Growth Roadmap for U.S. Disposable POC Testing Companies
FIGURE 127: Go-to-Market, CLIA-Waiver and OTC Commercialization Framework
FIGURE 128: Product Positioning and Portfolio Expansion Framework
FIGURE 129: Report Scope and Disclaimer Framework